Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer

Chitta Ranjan Patra, Resham Bhattacharya, Debabrata Mukhopadhyay, Priyabrata Mukherjee

Research output: Contribution to journalReview articlepeer-review

307 Scopus citations


The targeted delivery of a drug should result in enhanced therapeutic efficacy with low to minimal side effects. This is a widely accepted concept, but limited in application due to lack of available technologies and process of validation. Biomedical nanotechnology can play an important role in this respect. Biomedical nanotechnology is a burgeoning field with myriads of opportunities and possibilities for advancing medical science and disease treatment. Cancer nanotechnology (1-100 nm size range) is expected to change the very foundations of cancer treatment, diagnosis and detection. Nanomaterials, especially gold nanoparticles (AuNPs) have unique physico-chemical properties, such as ultra small size, large surface area to mass ratio, and high surface reactivity, presence of surface plasmon resonance (SPR) bands, biocompatibility and ease of surface functionalization. In this review, we will discuss how the unique physico-chemical properties of gold nanoparticles may be utilized for targeted drug delivery in pancreatic cancer leading to increased efficacy of traditional chemotherapeutics.

Original languageEnglish (US)
Pages (from-to)346-361
Number of pages16
JournalAdvanced Drug Delivery Reviews
Issue number3
StatePublished - Mar 8 2010


  • Anti-cancer drugs
  • AuNPs
  • Colloidal gold nanoparticles
  • Drug delivery
  • EGFR
  • Fabrication
  • Gold nanoparticles
  • Pancreatic cancer
  • Targeted therapy
  • Tyrosine kinase

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer'. Together they form a unique fingerprint.

Cite this